Product Description
invendoscope for colonoscopy (Sourced from: https://www.prnewswire.com/news-releases/invendo-medical-announces-510k-clearance-by-fda-for-advancement-assisted-single-use-colonoscopy-system-140277593.html)
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: Device
Route of Administration: Subcutaneous
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Ferring
Company Location: Europe
Company Founding Year: 1950
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 4: Obesity|Neuromyelitis Optica|Adenoma|Pelvic Inflammatory Disease
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT02279836 |
SC20 Scope | P4 |
Terminated |
Adenoma|Neuromyelitis Optica|Pelvic Inflammatory Disease|Obesity |
2015-10-01 |
2019-03-20 |
Treatments |